Zoetis
Trade Zoetis 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ZTS
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments.
ZTS Key Statistics
Stock Snapshot
As of today, Zoetis(ZTS) shares are valued at $79.45. The company's market cap stands at 32.82B, with a P/E ratio of 13.49 and a dividend yield of 2.67%.
During the trading session on 2026-11-07, Zoetis(ZTS) shares reached a daily high of $80.98 and a low of $78.66. At a current price of $79.45, the stock is +1.0% higher than the low and still -1.9% under the high.
Trading volume for Zoetis(ZTS) stock has reached 6.02M, versus its average volume of 4.98M.
Over the past 52 weeks, Zoetis(ZTS) stock has traded between a high of $132.49 and a low of $68.77.
Over the past 52 weeks, Zoetis(ZTS) stock has traded between a high of $132.49 and a low of $68.77.
ZTS News
Zoetis ((ZTS)) has held its Q3 earnings call. Read on for the main highlights of the call. Zoetis delivered a mixed third-quarter performance, combining resili...
...
On its third-quarter 2026 earnings call, held on Nov. 5, 2026, Zoetis (ZTS -7.95%) reported a 1% revenue decline, excluding currency and acquisition effects. Lo...
Analyst ratings
72%
of 18 ratingsMore ZTS News
Zoetis Inc. (NYSE:ZTS) reported third-quarter adjusted earnings of $1.75 per share, beating the consensus of $1.51. The animal health company reported sales of...
Technology Zoetis Adds To 21% Monthlong Run, Barking Up A Third-Quarter Beat Licensing Zoetis (ZTS) stock rose early Thursday after the pet health giant reporte...
For the quarter ended September 2026, Zoetis (ZTS Quick QuoteZTS - Free Report) reported revenue of $2.39 billion, down 0.4% over the same period last yea...
has enjoyed a sharp rebound in recent weeks after a long slide. This puts a fresh spotlight on whether the current share price lines up with what its earnings c...
Advertisement Why the new Convenia approval matters for Zoetis Zoetis (ZTS) just received FDA approval for Convenia RTU for Dogs, a single dose injectable ant...
Zoetis reported that the FDA approved Convenia RTU for Dogs, a more concentrated cefovecin injection that delivers up to 14 days of treatment for susceptible ba...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.